[PSAD and PSA-AD in the early diagnosis of cancer of the prostate].
Presentation and analysis of results from an early diagnosis program for prostate cancer in symptomatic patients. Output of density-PSA (PASD-d), density-PSA of the transitional area (PSAD-ad) and free PSA/total PSA ratio, applied to patients with total PSA between 4 and 10 ng/ml is analyzed.
Allepuz Losa
C
C
Servicio de Urología, Hospital Miguel Servet, Zaragoza.
Sanz
J I
JI
Carela
J
J
Benejam
J
J
García-Miralles
R
R
Rioja Sanz
L A
LA
D000236:Adenoma / Q000097:blood / Q000175:diagnosis* / Q000473:pathology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001706:Biopsy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010173:Palpation; D011467:Prostate / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000473:pathology; D012372:ROC Curve; D012016:Reference Values; D012680:Sensitivity and Specificity
D017430:Prostate-Specific Antigen
Aportación del PSAD y PSA-AD en el diagnóstico precoz del cáncer de próstata.